EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY 4.0

Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis

Jamir Pitton Rissardo iD, Ana Leticia Fornari Caprara iD

Clinics and Practice · 03.06.2025 · 15 (6) · 107

DOI: 10.3390/clinpract15060107 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics and Practice, online erschienen am 03.06.2025. Verfasst von Jamir Pitton Rissardo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Cooper University Hospital, Camden, NJ 08103, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and objective: Assessment of α-synuclein (αSyn) seed amplification assays (αSyn-SAA) accuracy in distinguishing Parkinson’s disease (PD) from controls using cerebrospinal fluid (CSF), blood, skin, extracellular vesicles (ECV), saliva, olfactory mucosa (OM), gastrointestinal tract (GIT), and submandibular gland (SMG). Methodology: PubMed was searched for articles from 2010 to January 2025. The quality assessment used robvis. Diagnostic values with a 95% confidence interval (CI) were obtained. Z-test, Wald CI, and ANOVA were performed. Diagnostic odds ratio (DOR) was used. Results: αSyn-SAAs showed strong diagnostic performance in distinguishing PD from controls across various tissue and fluid types. Overall, αSyn-SAAs demonstrated high sensitivity (86%) and specificity (92%). Among all biomatrices, CSF, skin, blood, and ECV yielded the highest diagnostic accuracy, with sensitivity and specificity approaching or exceeding 90%. In contrast, saliva, oral mucosa, and gastrointestinal tract samples showed more modest sensitivity, though specificity remained relatively high. ECV, CSF, skin, and blood matrices also demonstrated the highest DOR, supporting their potential clinical utility. Conclusions: ECV and blood warrant priority in αSyn-SAA for high accuracy and minimal invasiveness, while GIT, OM, and oral samples show limited utility; saliva and SMG need refinement.

Schlagwörter

Stichwörter der Autor:innen

alpha-synucleinbiofluidbiomarkerprotein misfolding cyclic amplification (PMCA)real-time quaking-induced conversion (RT-QuIC)synucleinopathy

Autor:innen und Institutionen

  • Neurology Department, Cooper University Hospital, Camden, NJ 08103, USA.

ORCID-Profile: Jamir Pitton Rissardo, Ana Leticia Fornari Caprara

Zitieren

APA

Rissardo, J. P., & Fornari Caprara, A. L. (2025). Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis. Clinics and Practice, 15(6), 107. https://doi.org/10.3390/clinpract15060107

Vancouver

Rissardo JP, Fornari Caprara AL. Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis. Clinics and Practice. 2025;15(6):107. doi:10.3390/clinpract15060107

BibTeX
@article{Rissardo2025,
  author = {Rissardo, Jamir Pitton and Fornari Caprara, Ana Leticia},
  title = {Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis},
  journal = {Clinics and Practice},
  year = {2025},
  volume = {15},
  number = {6},
  pages = {107},
  doi = {10.3390/clinpract15060107}
}
Kostenlos starten →